12010 related articles for article (PubMed ID: 11374804)
1. Expression of P53 protein in primary uveal melanoma.
Sulkowski S; Sulkowska M; Famulski W; Chyczewski L; Bakunowicz-Lazarczyk A
Folia Histochem Cytobiol; 2001; 39(2):159-60. PubMed ID: 11374804
[TBL] [Abstract][Full Text] [Related]
2. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical detection of the gene p53 and p21 expression in cells of the malignant melanoma of the uvea].
Tokosová E; Hermanová M; Uhmannová R; Smardová J; Hlinomazová Z
Cesk Slov Oftalmol; 2008 Jul; 64(4):153-6. PubMed ID: 18780655
[TBL] [Abstract][Full Text] [Related]
4. c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma.
Chana JS; Wilson GD; Cree IA; Alexander RA; Myatt N; Neale M; Foss AJ; Hungerford JL
Br J Ophthalmol; 1999 Jan; 83(1):110-4. PubMed ID: 10209447
[TBL] [Abstract][Full Text] [Related]
5. p53 expression in uveal malignant melanomas.
Jay V; Yi Q; Hunter WS; Zielenska M
Pathology; 1996 Nov; 28(4):306-8. PubMed ID: 9007946
[TBL] [Abstract][Full Text] [Related]
6. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma.
Shah AA; Bourne TD; Murali R
Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma.
Sun Y; Tran BN; Worley LA; Delston RB; Harbour JW
Invest Ophthalmol Vis Sci; 2005 May; 46(5):1561-4. PubMed ID: 15851551
[TBL] [Abstract][Full Text] [Related]
8. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
[TBL] [Abstract][Full Text] [Related]
9. Study of P53 protein expression in colorectal cancer.
Sulkowska M; Famulski W; Guzińska-Ustymowicz K; Sulkowski S
Folia Histochem Cytobiol; 2001; 39(2):157-8. PubMed ID: 11374803
[TBL] [Abstract][Full Text] [Related]
10. Deregulation of the Rb and p53 pathways in uveal melanoma.
Brantley MA; Harbour JW
Am J Pathol; 2000 Dec; 157(6):1795-801. PubMed ID: 11106551
[TBL] [Abstract][Full Text] [Related]
11. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss.
Coupland SE; Vorum H; Mandal N; Kalirai H; Honoré B; Urbak SF; Lake SL; Dopierala J; Damato B
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):12-20. PubMed ID: 19643972
[TBL] [Abstract][Full Text] [Related]
12. Inverse correlation between expression of HLA-B and c-myc in uveal melanoma.
Blom DJ; Mooy CM; Luyten GP; Kerkvliet S; Ouwerkerk I; Zwinderman AH; Schrier PI; Jager MJ
J Pathol; 1997 Jan; 181(1):75-9. PubMed ID: 9072006
[TBL] [Abstract][Full Text] [Related]
13. p53 Immunoreactivity, Ki-67 expression, and microcirculation patterns in melanoma of the iris, ciliary body, and choroid.
Chowers I; Folberg R; Livni N; Pe'er J
Curr Eye Res; 2002 Feb; 24(2):105-8. PubMed ID: 12187481
[TBL] [Abstract][Full Text] [Related]
14. [Expression of bcl-2, Ki-67 and p-53 in uveal melanomas].
Krvavica A; Talan-Hranilović J; Belicza M
Acta Med Croatica; 2008 Jul; 62(3):267-71. PubMed ID: 18843846
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of tissue inhibitor of matrix metalloproteinases 3 in uveal melanoma.
Nareyeck G; Zeschnigk M; von der Haar D; Schilling H; Bornfeld N; Anastassiou G
Ophthalmic Res; 2005; 37(1):23-8. PubMed ID: 15637418
[TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
[TBL] [Abstract][Full Text] [Related]
17. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
[TBL] [Abstract][Full Text] [Related]
18. Expression of p53 protein in malignant melanoma: clinicopathological and prognostic implications.
Weiss J; Heine M; Körner B; Pilch H; Jung EG
Br J Dermatol; 1995 Jul; 133(1):23-31. PubMed ID: 7669636
[TBL] [Abstract][Full Text] [Related]
19. Possible implications of MCAM expression in metastasis and non-metastatic of primary uveal melanoma patients.
Beutel J; Wegner J; Wegner R; Ziemssen F; Nassar K; Rohrbach JM; Hilgers RD; Lüke M; Grisanti S
Curr Eye Res; 2009 Nov; 34(11):1004-9. PubMed ID: 19958117
[TBL] [Abstract][Full Text] [Related]
20. [Study of a role of the expression of a transmembranous CD117/C-Kit receptor in the progression of uveal melanomas].
Anurova OA; Likhvantseva VG; Vereshchagina MV
Vestn Oftalmol; 2007; 123(5):41-4. PubMed ID: 18078058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
